je.st
news
Tag: now
You'll Need That Kleenex From Kimberly-Clark Corporation If You Buy Shares Now
2015-10-18 10:09:16| Paper - Topix.net
Consumer staples offer downside protection to investors since they have generally inelastic demand for their products and also have pricing power over the medium term. With the bull market being a bit long in the tooth and lasting about 6.5 years now I feel it's important to figure out my potential buy zones on some of the greatest defensive companies around, consumer staples.
Tags: you
now
buy
corporation
Albertsons Companies IPO: Investors Should Hold Off For Now
2015-10-15 23:21:34| Grocery - Topix.net
ABS expects to raise a whopping $1.59 billion in its upcoming IPO, set to price this Wed., Oct. 15th. Lead underwriters are BofA Merrill Lynch, Citigroup, Goldman and Morgan Stanley.
Tags: now
companies
hold
investors
Satechi Wireless Gamepad for mobile devices now available
2015-10-14 21:12:29| Wireless - Topix.net
Satechi has introduced and formally launched its new Wireless Gamepad, a Bluetooth gaming controller that works with iOS, Android, and Windows devices. The controller can be used with both smartphones and tablets, featuring a spring holder for attaching phones.
Tags: now
mobile
wireless
devices
iPad Mini 4 is available now
2015-10-14 12:52:47| Wireless - Topix.net
Product: iPad Mini 4 Website: Apple Specifications: 7.9in LED-backlit widescreen Multi-Touch, 2048x1536 resolution at 326ppi Retina display, A8 64-bit processor with M8 motion coprocessor, 2GB of RAM, 16GB/64GB/128GB of internal storage, 8MP rear camera with HD 1080p video, 1.2MP front camera, 802.11a/b/g/n/ac WiFi, 4G LTE support, iOS 9, 19.1 watt-hour rechargeable lithium-polymer battery, 203x135x6.1mm, 299g. Price: From 319 The new version offers a processor upgrade, a slimline and lightweight design, and proper multi-tasking abilities.
Armed With FDA Orphan Drug Status in the U.S., PharmaCyte Biotech Now ...
2015-10-10 05:30:50| Biotech - Topix.net
In the world of biopharma, it doesn't take long for a company to copy or mimic a popular, successful drug. In fact, for some less-common diseases, the industry realizes that merely sharing the revenue generated by a small niche may not even be worth the effort, meaning those rare or difficult-to-treat diseases often go completely unaddressed.
Sites : [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] next »